| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 31, 2024 | CPIX Cumberland Pharmaceuticals Inc | Kazimi A J59 | Chairman And CEO | Buy | 1,426 | $1.28 | $1,827.14 | - | +100.0% | +167.0% | |
| Oct 31, 2024 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth54 | Director | Buy | 7,107 | $1.28 | $9,106.23 | +0.1% | +100.0% | +167.0% | |
| Oct 31, 2024 | CPIX Cumberland Pharmaceuticals Inc | Jones James53 | Director | Buy | 1,426 | $1.28 | $1,827.14 | +0.2% | +100.0% | +167.0% | |
| Oct 31, 2024 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 713 | $1.28 | $913.57 | +0.1% | +100.0% | +167.0% | |
| Oct 30, 2024 | PFE Pfizer Inc | Gottlieb Scott | Director | Buy | 1,000 | $28.24 | $28,240.00 | +11.1% | -6.2% | -14.8% | |
| Oct 30, 2024 | BIOE Bio Essence Corp | Yan Yin | Chief Executive Officer | Sell | 323,845 | $1.41 | $455,191.65 | -42.9% | - | - | |
| Oct 29, 2024 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 2,339 | $23.16 | $54,171.24 | -1.4% | +37.2% | +109.7% | |
| Oct 29, 2024 | SCLX Scilex Holding Co | Shah Jaisim | See Remarks | Buy | 32,000 | $0.99 | $31,670.40 | +41.4% | -53.8% | -47.0% | |
| Oct 28, 2024 | UTHR United Therapeutics Corp | Edgemond James | CFO And Treasurer | Sell | 7,800 | $350.00 | $2,730,000.00 | -21.4% | +5.7% | +18.8% | |
| Oct 28, 2024 | LQDA Liquidia Corp | Adair Jason | Chief Business Officer | Sell | 459 | $11.31 | $5,190.42 | -0.4% | +27.0% | +109.9% | |
| Oct 25, 2024 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 17,304 | $22.00 | $380,688.00 | -8.2% | +42.2% | +124.5% | |
| Oct 24, 2024 | ELTP Elite Pharmaceuticals Inc /nv/ | Plassche Douglas | SVP Of Operations | Sell | 1,133,932 | $0.50 | $562,305.32 | -77.3% | - | - | |
| Oct 23, 2024 | ETST Earth Science Tech, Inc. | Sanchez Yovan Arturo | Director | Buy | 50,000 | $0.14 | $7,000.00 | +4.2% | - | - | |
| Oct 23, 2024 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 10,000 | $7.98 | $79,814.00 | +0.4% | +87.8% | +128.0% | |
| Oct 21, 2024 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 7,500 | $22.20 | $166,500.00 | -3.7% | +29.3% | +114.1% | |
| Oct 21, 2024 | UTHR United Therapeutics Corp | Edgemond James | CFO And Treasurer | Sell | 7,782 | $366.99 | $2,855,916.18 | -22.7% | -0.7% | +14.0% | |
| Oct 18, 2024 | LQDA Liquidia Corp | Saggar Rajeev | Chief Medical Officer | Sell | 2,526 | $11.19 | $28,265.94 | -1.2% | +12.3% | +101.8% | |
| Oct 18, 2024 | SCLX Scilex Holding Co | Chun Jay | Director | Buy | 5,000 | $0.95 | $4,750.00 | +4.7% | -51.6% | -62.4% | |
| Oct 18, 2024 | SCLX Scilex Holding Co | Followwill Dorman | Director | Buy | 1,000 | $0.99 | $990.00 | +76.9% | -51.6% | -62.4% | |
| Oct 17, 2024 | SCLX Scilex Holding Co | Wu Yue Alexander | Director | Buy | 20,000 | $0.95 | $18,992.00 | +400.0% | -52.9% | -61.4% | |
| Oct 17, 2024 | SCLX Scilex Holding Co | Ji Henry | Executive Chairperson | Buy | 10,000 | $0.97 | $9,710.00 | +20.0% | -52.9% | -61.4% | |
| Oct 17, 2024 | SCLX Scilex Holding Co | Lemus David | Director | Buy | 2,000 | $0.90 | $1,800.00 | New | -52.9% | -61.4% | |
| Oct 17, 2024 | ESPR Esperion Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Sell | 107 | $2.12 | $226.73 | - | +4.7% | +30.3% | |
| Oct 16, 2024 | SCLX Scilex Holding Co | Shah Jaisim | See Remarks | Buy | 30,000 | $0.99 | $29,751.00 | +63.4% | -48.3% | -56.3% | |
| Oct 16, 2024 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 471 | $22.64 | $10,663.44 | -8.4% | +17.2% | +164.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.